Why might a 50-year-old patient with type 2 diabetes mellitus have an elevated ferritin level?

Elevated Ferritin in Type 2 Diabetes: Common Causes

In a 50-year-old with type 2 diabetes, elevated ferritin is most commonly due to inflammation and metabolic dysfunction rather than true iron overload, though several other important causes must be systematically excluded.

Primary Mechanism: Metabolic Hyperferritinemia

Ferritin is an acute phase reactant that becomes elevated in diabetes through multiple mechanisms 1, 2, 3:

• Chronic inflammation: Type 2 diabetes creates a pro-inflammatory state that directly raises ferritin independent of iron stores
• Insulin resistance: Strong positive correlation exists between ferritin levels and insulin resistance 4, 5
• Hepatic dysfunction: Non-alcoholic fatty liver disease (NAFLD/MASLD) commonly coexists with diabetes and elevates ferritin 6, 7

Recent high-quality evidence demonstrates that approximately 80% of people with hyperferritinemia and type 2 diabetes have MASLD, with over one-third having significant hepatic fibrosis 7. The 2025 prospective study found hyperferritinemia remained an independent predictor of MASLD even after adjusting for obesity and insulin use.

Systematic Differential Diagnosis

Before attributing elevated ferritin solely to diabetes, you must exclude these conditions 2, 3, 8:

1. Check Transferrin Saturation First

• If transferrin saturation <45%: Likely metabolic hyperferritinemia, not true iron overload 2, 3
• If transferrin saturation ≥45-50%: Proceed to evaluate for hemochromatosis with HFE genetic testing 9, 2, 3

2. Common Confounding Conditions 8, 6

• Alcohol consumption: >14 drinks/week (women) or >21 drinks/week (men) elevates ferritin
• NAFLD/metabolic syndrome: Check ALT, AST, BMI, lipids, blood pressure
• Active inflammation: Measure CRP; elevated CRP with elevated ferritin suggests inflammatory process 8
• Cell necrosis: Check AST, ALT, CK for hepatocellular or muscle injury
• Chronic kidney disease: Ferritin >100 ng/mL common in CKD patients 1

3. Less Common but Important Causes 10, 11

• Malignancy (ferritin as tumor marker)
• Hemolysis (check haptoglobin, indirect bilirubin)
• Chronic viral hepatitis
• Autoimmune liver disease (though low-titer autoantibodies in NAFLD are often clinically insignificant 6)

Clinical Significance in Diabetes

The 2024 research demonstrates serum ferritin correlates strongly with HbA1c (ρ=0.871, p<0.001) and worsening glycemic control in type 2 diabetes 4, 5. Elevated ferritin independently predicts:

• Diabetic retinopathy (OR 3.96 in men, 2.47 in women) 12
• Coronary heart disease (OR 2.61 in men, 2.29 in women) 12
• Microalbuminuria (particularly in men) 12
• Hepatic fibrosis 7

Practical Diagnostic Algorithm

Step 1: Measure transferrin saturation alongside ferritin

• Normal transferrin saturation (<45%) + elevated ferritin = likely metabolic hyperferritinemia
• Elevated transferrin saturation (≥45-50%) = proceed to HFE genotyping 2, 3

Step 2: Assess for confounding factors

• Alcohol history (quantify drinks per week)
• CRP (inflammation marker)
• Liver enzymes (ALT, AST)
• Metabolic parameters (BMI, lipids, blood pressure)
• Kidney function (creatinine, GFR)

Step 3: If ferritin >1000 μg/L with elevated liver enzymes

• Consider liver biopsy to assess for cirrhosis 2, 3
• Evaluate for hepatocellular carcinoma risk

Critical Pitfalls to Avoid

1. Don't assume iron overload based on ferritin alone: Over 90% of hyperferritinemia cases have identifiable non-iron causes 8

2. Don't miss hemochromatosis: Always check transferrin saturation; ferritin can be elevated in hemochromatosis patients with normal ferritin if they have concurrent inflammation 9, 2

3. Don't ignore the liver: Ferritin >200 μg/L (women) or >300 μg/L (men) with diabetes warrants NAFLD evaluation 3, 6

4. Recognize sex differences: Men with diabetes and hyperferritinemia show more pronounced metabolic derangements including dyslipidemia and renal dysfunction 12

5. Context matters for anemia: The association between ferritin and diabetic complications is absent in patients with anemia 13, suggesting different pathophysiology

1, 2, 3, 8, 6, 4, 5, 7, 12